Develops and sells a wearable insulin pump for people with type one or type two diabetes who require insulin.
10-K for FY2026, filed Jun 29, 2026We are a medical device company focused on the design, development, and commercialization of innovative insulin pumps using modernized…View ↗
No revenue reported yet.
10-K, filed Jun 29, 2018
Its pumps are intended for people with type 1 diabetes and people with type 2 diabetes who need mealtime insulin; the company names people with type 1 diabetes as its initial target market.
10-K for FY2026, filed Jun 29, 2026
10-Q for Q1 FY2027, filed Aug 14, 2026
−$6.5MView ↗
From the initial pump to Pivot
The earlier report centered on the company's initial pump; the latest centers on Pivot and says the company will not commercialize that earlier product.
10-K for FY2023, filed Jun 26, 2023 10-K for FY2026, filed Jun 29, 2026We are a medical device company focused on the design, development, and commercialization of innovative insulin pumps using modernized…View ↗
Competes with Insulet, Tandem, Minimed, Mannkind, Cequr, Beta Bionics, and Deka
10-K for FY2026, filed Jun 29, 2026Insulet — commercializes a disposable patch pump, which held approximately 43% of the US market in 2026.View ↗
Loading...